NCT01527188 - Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model | Biotech Hunter

Enrollment

355

Participants

Timeline

Start Date

December 8, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

September 19, 2012

Conditions

Allergic Rhinitis Due to House Dust Mite

Interventions

DRUG

100 IR house dust mites allergen extract tablet

One sublingual tablet daily during 6 months

DRUG

300 IR house dust mites allergen extract tablet

One sublingual tablet daily during 6 months

DRUG

500 IR house dust mites allergen extract tablet

One sublingual tablet daily during 6 months

DRUG

Placebo tablet

One sublingual tablet daily during 6 months

Trial Locations (1)

Cetero Research, Mississauga